HST Global Inc. Shares (Common)

Shares (Common) of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shares (Common) growth rates and interactive chart. Number of common shares outstanding in a company.


Highlights and Quick Summary

  • Shares (Common) for the quarter ending June 29, 2020 was $4.25 Million (a 0.0% decrease compared to previous quarter)
  • Year-over-year quarterly Shares (Common) decreased by -0.05%
  • Annual Shares (Common) for 2019 was $4.25 Million (a 73.53% increase from previous year)
  • Annual Shares (Common) for 2018 was $2.45 Million (a -0.05% decrease from previous year)
  • Annual Shares (Common) for 2017 was $2.45 Million (a 0.0% decrease from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shares (Common) of HST Global Inc.

Most recent Shares (Common)of HSTC including historical data for past 10 years.

Interactive Chart of Shares (Common) of HST Global Inc.

HST Global Inc. Shares (Common) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $4.25 $4.25
2019 $4.25 $4.25 $3.45 $2.45 $4.25
2018 $2.45 $2.45 $2.45 $2.45 $2.45
2017 $2.45 $2.45 $2.45 $2.45 $2.45
2016 $2.45 $2.45 $2.45 $2.45 $2.45
2015 $2.45 $2.45 $2.45 $2.45 $2.45
2014 $2.45 $2.45 $2.45 $2.45 $2.45
2013 $2.45 $2.45 $2.45 $2.45 $2.45
2012 $2.45 $2.45 $2.45 $2.45 $2.45
2011 $2.45 $2.45
2010 $1.92 $1.92
2009 $1.68 $1.68

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.